Primaris REIT (TSX:PMZ.UN) presented its third-quarter 2026 investor deck on October 29, positioning itself as Canada’s only ...
October 29, 2026) - Enodia Therapeutics, a biotechnology company developing small-molecule therapies targeting a unique form ...
A new review describes how aberrant DNA methylation and premature senescence of fat cell precursors drive adipose tissue ...
PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) ("PharmaTher" or the "Company"), a specialty pharmaceutical and technology company advancing pharmaceutical 3D printing for personalized medicine, ...
Bank of America reiterates Microsoft as buy The firm raised its price target to $630 per share from $600 following earnings on Wednesday. "Microsoft delivered strong 1Q27 results, with the focal point ...
Barchart on MSN
Earnings preview: What to expect from Nordson’s report
Nordson Corporation (NDSN) is a global precision manufacturing technology company headquartered in Westlake, Ohio. It ...
Timothy A. Yap, MBBS, Ph.D., FRCP, of The University of Texas MD Anderson Cancer Center to present results from the dose escalation phase of the ...
A new review synthesizes how rewired fatty acid synthesis, storage, transport and palmitoylation drive glioblastoma ...
I've been feeling lately that while I've been having Ask Studio's AI come up with titles, they are indeed phrases and ...
. First submissions for regulatory approval are anticipated by mid-2028.
Discover how Hancom's new AI workforce platform, Nomadian, is set to revolutionize global business with role-based AI teams.
C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today highlighted its novel DNA-encoded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results